Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin R Kozak

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Cancer Biology & Therapy|March 12, 2009
A one, two punch for liver cancer: anti-angiogenesis with a death receptor agonistJohn P Plastaras, Kevin R Kozak
Journal of Surgical Oncology|July 11, 2008
The impact of T and N stage on long-term survival of rectal cancer patients in the communityKevin R Kozak, John S Moody
Oncology (Williston Park, N.Y.)|May 20, 2010
Optimizing outcomes of chemoradiation in the management of squamous cell carcinoma of the anal canalDerek R McHaffie, Kevin R Kozak
Neuro-Oncology|April 1, 2009
Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosisKevin R Kozak, John S Moody
International Journal of Radiation Oncology, Biology, Physics|February 6, 2008
The survival impact of the intergroup 0116 trial on patients with gastric cancerKevin R Kozak, John S Moody
Physics in Medicine and Biology|September 14, 2012
Computational modelling of anti-angiogenic therapies based on multiparametric molecular imaging dataBenjamin Titz, Kevin R Kozak, Robert Jeraj
American Journal of Clinical Oncology|March 11, 2010
Refusal of radiation therapy and its associated impact on survivalMaryam Hamidi, John S Moody, Kevin R Kozak
Current Treatment Options in Oncology|May 8, 2013
The role of radiation in retroperitoneal sarcomasPranshu Mohindra, Heather B Neuman, Kevin R Kozak
Neuro-Oncology|September 11, 2008
Adult gliosarcoma: epidemiology, natural history, and factors associated with outcomeKevin R Kozak, Anand Mahadevan, John S Moody
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma-An Easy Question Turned Difficult: Treat the Scan or the Patient?Tim J Kruser, Minesh P Mehta, Kevin R Kozak
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Cancer Biology & Therapy|March 12, 2009
A one, two punch for liver cancer: anti-angiogenesis with a death receptor agonistJohn P Plastaras, Kevin R Kozak
Journal of Surgical Oncology|July 11, 2008
The impact of T and N stage on long-term survival of rectal cancer patients in the communityKevin R Kozak, John S Moody
Oncology (Williston Park, N.Y.)|May 20, 2010
Optimizing outcomes of chemoradiation in the management of squamous cell carcinoma of the anal canalDerek R McHaffie, Kevin R Kozak
Neuro-Oncology|April 1, 2009
Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosisKevin R Kozak, John S Moody
International Journal of Radiation Oncology, Biology, Physics|February 6, 2008
The survival impact of the intergroup 0116 trial on patients with gastric cancerKevin R Kozak, John S Moody
Physics in Medicine and Biology|September 14, 2012
Computational modelling of anti-angiogenic therapies based on multiparametric molecular imaging dataBenjamin Titz, Kevin R Kozak, Robert Jeraj
American Journal of Clinical Oncology|March 11, 2010
Refusal of radiation therapy and its associated impact on survivalMaryam Hamidi, John S Moody, Kevin R Kozak
Current Treatment Options in Oncology|May 8, 2013
The role of radiation in retroperitoneal sarcomasPranshu Mohindra, Heather B Neuman, Kevin R Kozak
Neuro-Oncology|September 11, 2008
Adult gliosarcoma: epidemiology, natural history, and factors associated with outcomeKevin R Kozak, Anand Mahadevan, John S Moody
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma-An Easy Question Turned Difficult: Treat the Scan or the Patient?Tim J Kruser, Minesh P Mehta, Kevin R Kozak
Pageof 7